Herpes simplex virus vaccine
Patent Information
- Authority / Receiving Office
- US · United States
- Current Assignee / Owner
- GEN VEC INC
- Publication Date
- 2019-04-04
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This patent application is a continuation of copending U.S. patent application Ser. No. 15 / 618,740, filed Jun. 9, 2017, which is a continuation of U.S. patent application Ser. No. 14 / 403,397, filed Nov. 24, 2014, now U.S. Pat. No. 9,676,824, which is the U.S. national stage of International Patent Application No. PCT / US2013 / 041358, filed May 16, 2013, which claims the benefit of U.S. Provisional Patent Application 61 / 760,426, filed Feb. 4, 2013, and U.S. Provisional Patent Application 61 / 652,404, filed May 29, 2012, which applications are incorporated by reference.STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH AND DEVELOPMENT
[0002] This invention was made with Government support under Grant Number 5R43A1077147-02 awarded by the National Institutes of Health. The Government has certain rights in this invention.INCORPORATION-BY-REFERENCE OF MATERIAL ELECTRONICALLY SUBMITTED
[0003] Incorporated by reference in its entirety herein is a compute...